Skip to main content
    P

    Precision BioSciences Inc (DTIL)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.17
    +0.14 (+2.32%)

    Market Cap: $168.37M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    77%(23/30)
    Avg Surprise
    -62.00%
    Streak
    4 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.89
    Range$-1.19 - $-0.63
    3 analysts
    EPS RevisionsNo revisions (7d)
    1
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.61-45.9%
    60d ago$-0.65-37.6%
    30d ago$-0.65-37.6%
    7d ago$-0.85-4.3%
    Current$-0.89
    Revenue Consensus
    $1M
    Range$0 - $3M
    4 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-1.47
    Range$-2.04 - $-0.64
    3 analysts
    Revenue Consensus
    $7M
    Range$5M - $10M
    4 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-1.47---
    Sep 26EST
    		-$-0.89---
    Jun 26
    Reported Aug 6
    		$-0.71$-0.74+4.05%Beat+66.7%
    Mar 26
    Reported May 5
    		$-0.75$-0.81+7.41%Beat+66.1%
    Dec 25
    Reported Mar 12
    		$1.01$-0.64+256.37%Beat+147.1%
    Sep 25
    Reported Nov 3
    		$-1.84$-2.21+16.74%Beat+18.2%
    Jun 25
    Reported Aug 7
    		$-2.13$-0.09-2266.67%Miss-145.6%
    Mar 25
    Reported May 15
    		$-2.21$-0.43-413.95%Miss-230.0%
    Dec 24
    Reported Mar 26
    		$-2.14$-2.94+27.47%Beat+47.4%
    Sep 24
    Reported Nov 4
    		$-2.25$-3.13+28.11%Beat-7.1%
    Jun 24
    Reported Aug 1
    		$4.67$-5.07+192.11%Beat+255.7%
    Mar 24
    Reported May 13
    		$1.70$-1.91+189.01%Beat+126.0%
    Dec 23
    Reported Mar 27
    		$-4.06$-2.05-98.05%Miss-1461.5%
    Sep 23
    Reported Nov 7
    		$-2.10N/A+58.00%Beat+68.2%
    Jun 23
    Reported Aug 4
    		$-3.00N/A+60.00%Beat+78.3%
    Mar 23
    Reported May 9
    		$-6.55$-6.60+0.76%Beat+52.5%
    Dec 22
    Reported Mar 9
    		$-0.26$-0.21-23.81%Miss+50.0%
    Sep 22
    Reported Nov 8
    		$-6.60$-11.16+40.86%Beat-13.4%
    Jun 22
    Reported Aug 8
    		$-13.80$-13.92+0.86%Beat-227.8%
    Mar 22
    Reported May 9
    		$-13.80$-16.20+14.81%Beat-39.4%
    Dec 21
    Reported Mar 15
    		$-0.52$-0.47-10.64%Miss-18.2%
    Sep 21
    Reported Nov 10
    		$-5.82N/A+67.14%Beat+61.2%
    Jun 21
    Reported Aug 12
    		$10.80$-17.07+163.27%Beat+157.1%
    Mar 21
    Reported May 13
    		$-9.90$-16.47+39.89%Beat+36.5%
    Dec 20
    Reported Mar 18
    		$-0.44$-0.11-300.00%Miss-22.2%
    Sep 20
    Reported Nov 10
    		$-15.00$-20.33+26.22%Beat-22.0%
    Jun 20
    Reported Aug 13
    		$-18.90$-18.26-3.50%Miss-91.1%
    Mar 20
    Reported May 15
    		$-15.60$-16.00+2.50%Beat-36.8%
    Dec 19
    Reported Mar 10
    		$-0.36$-0.48+25.00%Beat-
    Sep 19
    Reported Nov 12
    		$-12.30$-13.58+9.43%Beat-8100.0%
    Jun 19
    Reported Aug 14
    		$-9.89$-12.98+23.81%Beat-
    Mar 19
    Reported Apr 29
    		$-11.40$-11.72+2.73%Beat-
    Dec 18
    Reported Mar 28
    		$0.00$0.00N/ABeat-
    Sep 18
    Reported Oct 19
    		$-0.15$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-2.69EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin-117.00%Operating Margin-80.80%
    ROE-135.10%ROIC-57.93%
    Financial Health
    Debt/Equity0.50xInterest Coverage1.84x
    Current Ratio12.82xQuick Ratio12.82x
    Trading Statistics
    Beta1.27Avg Volume272.56K
    52-Week High$9.6252-Week Low$3.53

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$6.30
    SMA 20$6.37
    SMA 50$7.12
    SMA 200$6.40
    EMA 10$6.29
    EMA 20$6.45
    EMA 50$6.85
    EMA 200$6.61

    MACD

    Line: -0.24Signal: -0.26Hist: 0.03

    ADX

    ADX: 17.1+DI: 16.9-DI: 22.9

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down96.0
    PSAR$6.90

    Bollinger Bands

    Upper Band$6.89
    Lower Band$5.84
    %B Position1644%(Upper)
    Band Width0.31

    RSI (14-Day)

    Neutral
    40.6

    Momentum Oscillators

    Stoch %K16.4
    Stoch %D26.1
    Williams %R-75.0
    ROC (10d)-2.5%
    Momentum-0.16
    CCI (20d)-94.8
    MFI (14d)54.0

    Volatility Measures

    ATR (14d)$0.37(6.0%)
    StdDev (20d)0.26
    Hist Vol68.0%(High)

    Volume Flow

    VWAP$6.12
    OBV5.2M
    AD Line-3.1M
    CMF (20d)-0.071

    Volume Metrics

    Avg Vol (20d)266.7K
    Vol Ratio0.9x
    VWMA (20d)$6.40

    Pivot Points

    R3$6.54
    R2$6.40
    R1$6.21
    Pivot Point$6.07
    S1$5.88
    S2$5.74
    S3$5.55

    Advanced Oscillators

    TSI-21.36
    Ultimate Osc47.3
    KST-131.85

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$10.84M$34.20M$13,000$18,000$29,000$638,000$576,000$49.90M$17.58M$7.04M$13.12M
    Cost of Revenue$0$0$678,000$0$0$0$757,000$0$0$0$1.56M$0
    Gross Profit$0$10.84M$34.20M$13,000$18,000$29,000$638,000$576,000$49.90M$17.58M$7.04M$13.12M
    Operating Expenses$19.16M$19.91M$22.13M$20.68M$21.92M$22.15M$25.30M$21.85M$25.94M$21.77M$21.92M$25.48M
    R&D$12.39M$13.11M$14.46M$13.35M$12.77M$13.59M$15.91M$13.08M$17.23M$13.34M$13.39M$15.85M
    SG&A$6.77M$6.80M$7.23M$7.33M$9.13M$8.55M$9.58M$8.77M$8.53M$8.43M$8.54M$9.63M
    Operating Income$-19,161,000$-9,075,000$12.51M$-20,667,000$-21,877,000$-22,112,000$-24,846,000$-21,275,000$24.15M$-4,187,000$-14,890,000$-12,363,000
    Interest Income$943,000$999,000$-4,597,000$436,000$451,000$2.67M$522,000$888,000$893,000$3.38M$956,000$520,000
    Interest Expense$300,000$311,000$348,000$362,000$358,000$354,000$392,000$256,000$560,000$574,000$579,000$576,000
    Income Before Tax$-32,653,000$-18,445,000$19.68M$-21,775,000$-23,495,000$-20,556,000$-17,934,000$-16,425,000$32.94M$8.59M$-13,443,000$-12,108,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-32,652,000$-18,441,000$20.13M$-21,772,000$-23,520,000$-20,565,000$-17,745,000$-16,425,000$32.75M$8.59M$-16,289,000$-8,079,000
    EBITDA$-32,695,000$-18,376,000$25.33M$-21,388,000$-23,056,000$-22,303,000$-17,475,000$-16,299,000$33.85M$7.33M$-12,413,000$-10,088,000
    EBIT$-33,296,000$-19,133,000$24.63M$-21,849,000$-23,588,000$-22,867,000$-18,064,000$-17,057,000$32.60M$5.79M$-13,820,000$-12,052,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about DTIL

    News

    Precision BioSciences stock has a November 2, 2026 earnings date

    Precision BioSciences (DTIL) is estimated to report its third-quarter 2026 results on November 2, 2026, with an anticipated loss of USD 0.85 per share and USD 1.38 million in revenue. The company previously reported...

    ad-hoc-news.de•10/15/26•Somewhat-Bearish

    Precision BioSciences, Inc. (DTIL) Stock Price Prediction for 2026, 2030-2040

    This article provides stock price predictions for Precision BioSciences, Inc. (DTIL) for the years 2026, 2030, and 2040...

    Traders Union•10/11/26•Neutral

    Precision BioSciences announces HBV talk: Precision BioSciences stock gains 1.79 percent

    Precision BioSciences' stock (DTIL) gained 1.79 percent, trading at EUR 5.68, following the announcement of a late-breaking oral presentation on its PBGENE-HBV program at The Liver Meeting 2026 on November 8...

    AD HOC NEWS•10/8/26•Somewhat-Bullish

    Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026

    Precision BioSciences (Nasdaq: DTIL) is set to deliver a late-breaking oral presentation on PBGENE-HBV at AASLD’s The Liver Meeting 2026. The presentation will discuss durable pgRNA loss in both HBeAg positive...

    Stock Titan•10/8/26•Somewhat-Bullish

    Precision BioSciences Announces Late-Breaking Oral Presentation for PBGENE-HBV at AASLD The Liver Meeting 2026

    Precision BioSciences will deliver a late-breaking oral presentation at The Liver Meeting 2026 for its PBGENE-HBV program...

    Yahoo! Finance Canada•10/8/26•Bullish

    DTIL Valuation and Fair Value

    P/E
    -2.7x
    Forward P/E
    11.8x
    P/B
    3.5x
    See GNG's fair value

    DTIL Profitability: Margins, ROIC and FCF

    Operating margin
    -80.8%
    Net margin
    -117.0%
    ROIC
    -57.9%
    ROE
    -135.1%
    FCF margin
    -115.3%

    DTIL Competitors

    CompanyTicker
    Whitehawk Therapeutics, Inc.WHWK
    Coherus BioSciences IncCHRS
    Oramed Pharmaceuticals IncORMP
    Innate PharmaIPHA
    Sutro BiopharmaSTRO
    PepGen LtdPEPG
    Invivyd Inc.IVVD
    Inogen IncINGN

    Sector: Healthcare

    DTIL Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    0
    Buy
    5
    Hold
    0
    Sell
    0
    Strong Sell
    0

    DTIL Bull Case vs Bear Case

    Bull case

    • DTIL beat EPS estimates in 75.0% of its last 8 reported quarters.
    • DTIL grew quarterly revenue 37272.0% year over year.
    • 100.0% of DTIL's analyst ratings are Buy or Strong Buy.

    Bear case

    • DTIL has a -117.0% net profit margin.

    DTIL Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    -292.6%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.89
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 2 down

    Frequently Asked Questions About DTIL

    Does DTIL pay dividends?

    Precision BioSciences Inc (DTIL) does not currently pay a regular dividend.

    What is DTIL's market cap?

    Precision BioSciences Inc (DTIL) has a market capitalization of $168.37M with a current stock price of $6.17.

    Related stocks

    Sector: Healthcare

    All stocks starting with D

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In